08/05/2026
For more than 20 years, many women have avoided menopausal hormone therapy because of fears surrounding breast cancer and heart disease.
Now, the FDA has changed the warning label on estrogen products to better reflect what research shows—including the importance of a woman’s age and when treatment begins.
This does not mean hormone therapy is right for everyone or that the risks should be ignored. It means women can have a more informed, individualized conversation about their care.
Dr. Mike explains what changed, which warning remains, and why timing matters:
The FDA estrogen warning label has changed. Learn what was removed, which risk remains, and why the timing of hormone therapy matters.